Participated · Series A · Oct 2023

Eden Brew uses a precision fermentation platform based on CSIRO-developed science to produce casein proteins that it says deliver the nutrition, functionality, sensory qualities and bioavailability of cow’s milk. The company was established in 2021 through a partnership between Norco, CSIRO and Main Sequence Ventures. Its core product focus is animal-free dairy ingredients and it plans to pilot its platform at commercial scale and expand research and manufacturing operations in Victoria. Eden Brew will move its head office to Melbourne and introduce a new ice cream product targeted at the food service industry. The company is pursuing regulatory and patent approvals in Australia, where precision fermentation-derived proteins are treated as novel foods requiring pre-market authorization. Financially, Eden Brew has completed a Series A and previously raised capital in 2022 to support scale-up and commercialization efforts.

Led · Seed · Apr 2022

Cerve provides a technology platform and APIs that enable organisations to build custom applications and automations across the food supply chain. The platform aims to drive profitability, commercial growth, reduce food waste and enhance food security by standardising data exchange and addressing legacy platform limitations. Today, over 2,000 organisations across the UK and Europe use Cerve’s infrastructure, including retailers, wholesalers, manufacturers and producers. The company plans to accelerate commercial expansion across the UK, Europe and North America and to strengthen its R&D capabilities. Hiring additional engineering, product and technical support teams is a stated priority for the use of funds. The company is led by founder and CEO Dan Mazig (with David Walker noted as CCO). Cerve is a Sweden-based food tech startup offering an infrastructure platform that automates wholesalers' sales operations. Its platform integrates with a wholesaler's ERP to digitize processes and provide a more tailored buying experience for B2B buyers. The company targets food and beverage wholesalers that remain dependent on manual processes and legacy backend systems, a problem highlighted during the pandemic and in the post-COVID digitization push. Cerve has raised a $2 million seed round, reflecting its current early-stage financing status. The seed was led by Orkla Ventures, with MP Pensjon and nFront Ventures joining the cap table. Daniel Holth Larsen of Orkla Ventures said Cerve 'hits the nail on the head' with its proven value proposition and looks forward to supporting the team on their journey.

Participated · Seed · Mar 2022

Bower offers a mobile app that leverages machine learning and computer vision to let users scan, identify, and better understand their waste, including package type, material composition, size and CO2e per item. The app rewards users for accurately sorting and depositing consumer packaging at regular recycling bins and provides real-time guidance and disposal instructions to local recycling facilities. Bower plans to open-source its computer vision model to benefit the wider recycling ecosystem and is developing a machine learning-powered waste collection experience with Google.org support. With backing from Google.org, the company aspires to save roughly 500,000 metric tons of CO2 equivalents annually by promoting sustainable behaviors and recycling practices. Operational metrics in the article note over half a million users, endorsements from more than 200 global and local brands, and over 80 million packages incentivized since the company started in 2019. Bower is a Stockholm-based green tech app that pays users money or coupons when they recycle everyday items by scanning barcodes. The platform lets users scan products—from milk cartons to crisp packets—and receive rewards when they take packaging to a recycling point. Brands using Bower can track product life cycles and use app data to understand item types, recycling times and locations. The company was founded in 2015 by siblings Suwar Mert (CEO) and Berfin Roza Mert (COO). Bower has partnerships with Nestlé, L’Oréal and Unilever and operates a free-to-use app with 300,000 users in the Nordics. Those users recycle more than 1.4 million packages monthly, and the platform says it has helped save over 1,000 tonnes of CO2; Bower raised €4.1M to expand internationally, starting with the U.K., and has raised €5M in total to date.

Led · Equity · Jun 2017

Your.MD is a London-based creator of the medical-grade, augmented intelligence self-care app Healthily. Founded in 2015 and led by CEO Matteo Berlucchi, the company combines augmented intelligence with medically validated information to deliver personalized health tools and support. Healthily gives individuals relevant health resources to enable self-care when appropriate, all in one place. In September the company introduced its first co-branded app in India with Dettol to help consumers take control of their health. The company raised $30m in Series A funding from Reckitt Benckiser. The investment will enable expansion across markets including the UK, India and the US. Your.MD operates an AI-driven “pre-primary care” service delivered through a conversational bot and available on web, iOS, Android, Facebook Messenger, Skype, Slack and Telegram. The product combines a symptom‑drilling chatbot with a next‑generation search engine that surfaces detailed, verified information on medical conditions. The company has also built the OneStop Health platform, a marketplace of trusted health service providers and products, with commercial partnerships (examples include Push Doctor and Urban Massage). There are currently 35 international and local digital health businesses on the OneStop platform, and the company plans to grow this to over 100 by the end of the year. OneStop is central to the company’s monetization strategy for what is otherwise a free information service. To date, Your.MD has 2.1 million downloads and reports nearly a million monthly active users, with a reported user base that is 67% male and 33% female. Your.MD offers a smartphone ‘smart health assistant’ that uses AI and machine learning plus licensed NHS data to give users information about conditions, likely causes and recommended next steps, including when to see a doctor. The app is positioned as an alternative to services such as NHS 111 and competitors like Symptomate, WebMD and Google Doctor. CEO Matteo Berlucchi says the product aims to act as a first-line, scalable alternative to waiting for doctor appointments by training AI to ask clinician-like questions and continuously learn from symptom patterns. The company says the system improves by correlating user symptoms and location data (for example, detecting local flu patterns). The app is free to users today, and the startup is eyeing value-added services such as the option to talk to a doctor, access more specialized information, and book tests. The company is London-based and emphasizes scalability through automation rather than relying on scarce clinical resources.